A Blood Test to Predict the Future

Thorac Cardiovasc Surg 2019; 67(06): 426-427
DOI: 10.1055/s-0038-1676608

Editorial

Georg Thieme Verlag KG Stuttgart · New York

Thomas V. Bilfinger

¹Department of Surgery, SUNY at Stony Brook, Stony Brook, New York, United States

References
1 https:// www.britannica.com/topic/Occams-razor
2 Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69 (03) 89-95
3 Naghavi M, Libby P, Falk E. , et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 2003; 108 (14) 1664-1672
4 Chow SL, Maisel AS, Anand I. , et al; American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Basic Cardiovascular Sciences; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Council on Quality of Care and Outcomes Research. Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association. Circulation 2017; 135 (22) e1054-e1091
5 Holmes FL. Claude Bernard, the milieu intérieur, and regulatory physiology. Hist Philos Life Sci 1986; 8 (01) 3-25